Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Clinical trial NCT06948214 · RECRUITING

Trial details

NCT number: NCT06948214
Sponsor: Lumos Pharma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency (GHD)

Start date: 2026-05-20
Primary completion: 2027-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.